VIT enters distribution agreement with MedReleaf Australia
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Vitura Health Limited has announced a binding commercial distribution agreement with MedReleaf Australia, allowing MedReleaf's products to be available on Vitura's Canview platform for the first time. The agreement is expected to potentially contribute significant additional annual revenue, although this is subject to various market factors. Vitura's Chief Revenue Officer emphasized the strategic importance of this partnership in enhancing product access for pharmacies and patients.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Vitura Health
- H1 FY26 Investor Presentation
- H1 FY26 Results Release
- H1 FY26 Appendix 4D and Half Year Report
- CEO Transition and Interim Leadership Update
- Declaration of dividend
Later from Vitura Health
- Appointment of Chief Executive Officer
- Doctors on Demand Performance Update
- Business Transformation Update
- Former CEO Legal Action Initiated
- FY2026 Financial Results
Follow Vitura Health into a list and get an email when it puts out news.
Follow Vitura Health